Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Aspirin and diabetes: The benefits and risks

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 29.01.20
Views: 195

Prof Francesco Cosentino - Karolinska Institutet, Stockholm, Sweden

Prof Francesco Cosentino speaks to ecancer at the International Aspirin Foundation Scientific Conference 2019 in Rome about the guidelines surrounding the use of aspirin in patients with diabetes.

He discusses which patients might benefit from using aspirin, but points out that the guidelines governing this are controversial.

Prof Cosentino mentions the ASCEND trial, which aims to investigate the use of aspirin as a preventative measure in diabetic patients.

Read more on the highlights from the 2019 International Aspirin Foundation Scientific Conference here.

Related videos

follow us

WIN 2020

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation